Navigation Links
Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
Date:3/9/2010

Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies.

Madison, WI (PRWEB) March 9, 2010 -- Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies. Under the agreement, the two companies are promoting the VivoGlo™ Caspase 3/7 Substrate for use with transgenic repTOP™ reporter mice. The tools allow the direct visualization and quantification of apoptosis non-invasively in live mice.

The study of apoptosis has generated much insight into the mechanisms of action of cancer over the past 20 years but nearly all studies to date have been performed in cells in culture and not in a more biologically relevant animal model such as mice.

TOP srl has developed a proprietary technology enabling the construction of transgenic animals in which the expression of imaging biomarkers is ubiquitous, tightly regulated, and constant among individual animals. Under the agreement, the transgenic repTOP reporter mice will contain an improved luciferase luc2 gene from Promega. It is now possible to study apoptotic processes in the whole live animal with these reporter mice with the same sensitivity and ease as in cell culture models, exploring physiology and pharmacological effects both spatially in different tissues and temporally. “We are pleased to be collaborating with Promega on the use of our transgenic mice with the VivoGlo Caspase 3/7 Substrate for studying apoptosis in vivo. The synergy of the two technologies is going to dramatically improve preclinical research for instance in oncology” said Paolo Ciana, PhD, Vice-President at TOP srl.

About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

About TOP srl
TOP srl is a leading company in the production of transgenic reporter mice for the application of in vivo imaging to drug discovery and development, basic research, and toxicology. TOP srl was founded in 2006 by Prof. Adriana Maggi and Dr. Paolo Ciana, of the University of Milan, is backed by the Next Fund of Finlombarda Gestioni SGR, and is based in Lodi, in Northern Italy. For more information, please visit the company’s website at www.top-mice.com

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3441444.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MedCAREERS GROUP, Inc. Reaches Agreement in Principle to Acquire StaffMD
2. Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories CRINONE(R) Progesterone Gel Product Line
3. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,800 Square Foot Medical Office Building in Mount Pleasant, South Carolina
4. TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company
5. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,300 Square Foot Medical Office Building in Sugar Land, Texas
6. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
7. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 260,500 Square Foot Medical Office Portfolio in Indiana
8. UCSF enters drug discovery agreement with Genentech
9. UCSF Enters Drug Discovery Agreement with Genentech
10. MedCath Enters Definitive Agreement To Sell Heart Hospital of Austin
11. Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire Lacombe Medical Office Building Near New Orleans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) is ... at 167 Lynch Creek Way. The Petaluma office features three comfortable patient exam ... rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. Neema ...
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. ... lift is mounted on wheels, it can be wheeled out of the way and stored ... to the deck. "We have transformed the feedback from customers into specific enhancements and created ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company based in ... children since the holiday season. , β€œIt happens every year around this time,” ... and taking photos, which is the head-to-head gateway that lice need to spread.” , ...
(Date:1/20/2017)... raton florida (PRWEB) , ... January 20, 2017 , ... ... at the Dana Farber Cancer Institute. For Betsy, the clinical trial has been ... her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the ... HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, ... 2013 - 2024" report to their offering. ... The global clinical laboratory testing ... Introduction of innovative solutions on the grounds of maximum efficiency ...
(Date:1/20/2017)... 2017  Palladian Health, a leading provider of ... of an opioid management program which assists physicians ... helps stem the growing tide of dependence on ... chronic non-cancer pain (back pain, neck pain, and ... of evidence regarding long-term effectiveness. The ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
Breaking Medicine Technology: